MYX mayne pharma group limited

Ann: Update on convertible note arrangements with Rubric Capital, page-8

  1. 1,522 Posts.
    lightbulb Created with Sketch. 269
    Yes Hadrian I agree Hadrian will do very well.
    Well we have no alternative but to hope this
    way. Your logic is exactly that and sensible.
    I would have liked Metrics ( Pharma CDMO
    company ) to have received 30 times . Should
    that have been the case we would have been
    paid $1.5b instead of $725b.
    There was also another option to raise $27.5m
    Get a Loan from bank . These comments we are
    debt free . Wrong ! We are paying interest on a loan
    albeit low 2.5% . Yes at first glance. The truth is it
    will cost us 9,6% of company. Exactly the same %
    Mithra received for Nextellis. Although at $10.20
    / share. With your rear view mirror positive outlook
    ( which I like ) Mayne could have repaid both the
    Bank Loan plus interest in 12 months thereby saving
    huge 10% dilution. Other than that I am in your corner.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$4.92
Change
-0.110(2.19%)
Mkt cap ! $399.7M
Open High Low Value Volume
$5.03 $5.03 $4.86 $1.730M 352.1K

Buyers (Bids)

No. Vol. Price($)
1 100 $4.88
 

Sellers (Offers)

Price($) Vol. No.
$4.93 25000 1
View Market Depth
Last trade - 16.15pm 23/06/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.